Related Experiment Video
Updated: Mar 20, 2026
11:15
Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts
Published on: September 1, 2018
8.5K
Developing immunotherapeutic strategies to target brain tumors
Nicole A P Lieberman1, Kara White Moyes1, Courtney A Crane1,2
1a Seattle Children's Research Institute, Ben Towne Center for Childhood Cancer Research , Seattle , WA , USA.
Expert Review of Anticancer Therapy
|June 3, 2016
Summary
Immunotherapy shows promise for brain tumors like glioblastoma (GBM). Overcoming the tumor microenvironment and activating immune cells are key to developing effective treatments.
Area of Science:
- Oncology
- Immunology
- Neuro-oncology
Background:
- Cancer immunotherapy has advanced significantly, showing success in blood cancers.
- Application of immunotherapy to brain tumors, particularly glioblastoma (GBM), remains challenging.
Purpose of the Study:
- To review current immunotherapeutic strategies for glioblastoma (GBM).
- To highlight mechanistic insights and clinical trial data for GBM immunotherapy.
Main Methods:
- Review of murine studies and clinical trial data for GBM immunotherapy.
- Analysis of past treatment failures and emerging therapeutic approaches.
Main Results:
- Glioblastoma (GBM) presents a unique challenge due to its immunosuppressive tumor microenvironment.
- Innate immune cell activation is a promising strategy to enhance anti-tumor activity.
Conclusions:
- Mitigating the immunosuppressive tumor microenvironment is crucial for effective GBM immunotherapy.
- New immunotherapies and immune monitoring protocols are needed for GBM patients.
Related Concept Videos
01:27Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
02:57Targeted Cancer Therapies
9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.1K